Allianz Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,800
| Closed | -$205K | – | 1683 |
|
|
2024
Q2 | $205K | Sell |
3,800
-11,992
| -76% | -$648K | ﹤0.01% | 1565 |
|
|
2024
Q1 | $1.08M | Buy |
15,792
+451
| +3% | +$30.7K | ﹤0.01% | 1225 |
|
|
2023
Q4 | $960K | Buy |
15,341
+1,300
| +9% | +$81.4K | ﹤0.01% | 1232 |
|
|
2023
Q3 | $637K | Sell |
14,041
-41,722
| -75% | -$1.89M | ﹤0.01% | 1379 |
|
|
2023
Q2 | $3.13M | Buy |
55,763
+1,712
| +3% | +$96.1K | 0.01% | 860 |
|
|
2023
Q1 | $2.44M | Buy |
54,051
+3,499
| +7% | +$158K | ﹤0.01% | 1007 |
|
|
2022
Q4 | $2.05M | Buy |
50,552
+209
| +0.4% | +$8.5K | ﹤0.01% | 1049 |
|
|
2022
Q3 | $3.29M | Buy |
50,343
+23,071
| +85% | +$1.51M | 0.01% | 908 |
|
|
2022
Q2 | $1.66M | Hold |
27,272
| – | – | ﹤0.01% | 1348 |
|
|
2022
Q1 | $1.71M | Sell |
27,272
-15,865
| -37% | -$995K | ﹤0.01% | 1407 |
|
|
2021
Q4 | $3.28M | Buy |
43,137
+1,075
| +3% | +$81.7K | ﹤0.01% | 1255 |
|
|
2021
Q3 | $4.71M | Sell |
42,062
-24,186
| -37% | -$2.71M | ﹤0.01% | 1118 |
|
|
2021
Q2 | $10.7M | Buy |
66,248
+40,421
| +157% | +$6.54M | 0.01% | 792 |
|
|
2021
Q1 | $3.15M | Buy |
25,827
+3,763
| +17% | +$458K | ﹤0.01% | 1136 |
|
|
2020
Q4 | $3.38M | Buy |
+22,064
| New | +$3.38M | ﹤0.01% | 1147 |
|
|
2020
Q2 | – | Sell |
-82,123
| Closed | -$3.48M | – | 1909 |
|
|
2020
Q1 | $3.48M | Buy |
82,123
+48,316
| +143% | +$2.05M | ﹤0.01% | 1093 |
|
|
2019
Q4 | $2.06M | Sell |
33,807
-5,869
| -15% | -$357K | ﹤0.01% | 1454 |
|
|
2019
Q3 | $1.64M | Sell |
39,676
-20,594
| -34% | -$849K | ﹤0.01% | 1521 |
|
|
2019
Q2 | $2.84M | Sell |
60,270
-19,246
| -24% | -$906K | ﹤0.01% | 1433 |
|
|
2019
Q1 | $2.84M | Buy |
79,516
+17,164
| +28% | +$613K | ﹤0.01% | 1439 |
|
|
2018
Q4 | $1.75M | Buy |
62,352
+2,527
| +4% | +$71K | ﹤0.01% | 1510 |
|
|
2018
Q3 | $2.65M | Sell |
59,825
-65,632
| -52% | -$2.91M | ﹤0.01% | 1489 |
|
|
2018
Q2 | $7.37M | Sell |
125,457
-107,287
| -46% | -$6.3M | 0.01% | 1073 |
|
|
2018
Q1 | $10.6M | Buy |
232,744
+684
| +0.3% | +$31.3K | 0.01% | 963 |
|
|
2017
Q4 | $5.45M | Buy |
232,060
+98,690
| +74% | +$2.32M | ﹤0.01% | 1188 |
|
|
2017
Q3 | $2.38M | Buy |
+133,370
| New | +$2.38M | ﹤0.01% | 1440 |
|